Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04257799 · ClinicalTrials.gov registry record
Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT04257799 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT04257799 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new surgical imaging system called "Structured Light Imaging (SLI)." This system is designed to examine tissue removed during breast cancer surgery to see whether the tissue's edges contain cancer. The current standard of practice is to remove the breast tumor tissue and send the tissue to the lab for analysis following surgery. One in five women (in the US) must later return for a second surgery to remove cancer cells that the lab found remaining in the tissue. In this study, researchers hope that the new SLI system may detect the cancer cells in the tissue's edges by imaging at the time of surgery. If successful, in the future we may use this system to improve entire cancer removal at the time of surgery, and reduce the need to perform a second surgery to remove additional breast tissue.
Interventions
- OTHER Structured Light Imaging (SLI) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2022-03-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04257799
The ClinicalTrials.gov registry entry for NCT04257799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Structured Light Imaging (SLI) System is the first listed.
NCT04257799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04257799 about?
NCT04257799 is a clinical study titled "Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging". The purpose of this study is to test a new surgical imaging system called "Structured Light Imaging (SLI)." This system is designed to examine tissue removed during breast cancer surgery to see whether the tissue's edges contain cancer. The current standard of practice is to remove the breast tumor ...
What is the current status of trial NCT04257799?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-02-06. Estimated completion is 2022-03-16.
What interventions are being tested in trial NCT04257799?
The interventions under investigation include: Structured Light Imaging (SLI) System (OTHER).
Who is sponsoring clinical trial NCT04257799?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.